InsiderTrades.com logo
[625,000% Gain] – Are You Ready for the Next Altcoin Boom?
From Crypto Swap Profits   |   Ad
All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.
Register for the FREE Workshop Now & get $10 in Bitcoin

LCTX Insider Trading

Insider Ownership Percentage: 26.60%
Insider Buying (Last 12 Months): $7,143,847.00
Insider Selling (Last 12 Months): $0.00

Lineage Cell Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Lineage Cell Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Lineage Cell Therapeutics Share Price & Price History

Current Price: $0.50
Price Change: ▼ Price Decrease of -0.1 (-16.56%)
As of 11/22/2024 01:00 AM ET

This chart shows the closing price history over time for LCTX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Buffett Dumps $982 Million in BofA Stock—What Does He Know?
From Genesis Gold Group   |   Ad
Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track record starts pulling out of the market, it's time to pay attention.
Get your FREE, no-obligation Wealth Protection Guide now

Lineage Cell Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/21/2024Brian M CulleyCEOBuy40,000$0.60$24,000.00194,842View SEC Filing Icon  
8/16/2024Jill Ann HoweCFOBuy10,500$0.89$9,345.0010,500View SEC Filing Icon  
5/24/2024Brian M CulleyCEOBuy10,000$1.05$10,500.00154,842View SEC Filing Icon  
2/8/2024Don M BaileyDirectorBuy96,155$1.04$100,001.20158,801View SEC Filing Icon  
2/6/2024Broadwood Partners, L.P.DirectorBuy6,730,770$1.04$7,000,000.8041,666,255View SEC Filing Icon  
3/31/2022Brian M CulleyCEOBuy6,400$1.53$9,792.0097,787View SEC Filing Icon  
3/28/2022Dipti AminDirectorBuy35,000$1.63$57,050.00View SEC Filing Icon  
3/25/2022Brian M CulleyCEOBuy5,250$1.38$7,245.00View SEC Filing Icon  
3/24/2022Michael H MulroyDirectorBuy7,000$1.40$9,800.00View SEC Filing Icon  
12/28/2021Gary S HoggeSVPSell501,588$2.45$1,228,890.60View SEC Filing Icon  
See Full Table
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
From Weiss Ratings   |   Ad
Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.
Learn these 4 simple steps and protect your savings before it’s too late.

SEC Filings (Institutional Ownership Changes) for Lineage Cell Therapeutics (NYSEAMERICAN:LCTX)

62.47% of Lineage Cell Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at LCTX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Lineage Cell Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/19/2024Barclays PLC211,300$0.19M0.0%+311.3%0.112%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC3,679,280$3.33M0.0%+2.3%1.948%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC211,300$0.19M0.0%+311.3%0.112%Search for SEC Filing on Google Icon
11/15/2024Jane Street Group LLC119,901$0.11M0.0%-50.6%0.063%Search for SEC Filing on Google Icon
11/15/2024State Street Corp2,608,352$2.36M0.0%+1.8%1.381%Search for SEC Filing on Google Icon
11/15/2024HighTower Advisors LLC38,606$35K0.0%-30.7%0.020%Search for SEC Filing on Google Icon
11/14/2024Raffles Associates LP4,507,781$4.08M4.2%+3.4%2.387%Search for SEC Filing on Google Icon
11/8/2024Connor Clark & Lunn Investment Management Ltd.191,436$0.17M0.0%-7.9%0.101%Search for SEC Filing on Google Icon
11/7/2024MAI Capital Management1,674,679$1.52M0.0%+2.2%0.887%Search for SEC Filing on Google Icon
11/5/2024GSA Capital Partners LLP93,032$84K0.0%N/A0.049%Search for SEC Filing on Google Icon
10/21/2024Defender Capital LLC.5,002,198$4.53M1.5%+0.6%2.649%Search for SEC Filing on Google Icon
10/3/2024SG Americas Securities LLC50,920$46K0.0%N/A0.027%Search for SEC Filing on Google Icon
8/27/2024Logos Global Management LP4,700,000$4.69M0.4%-24.8%2.489%Search for SEC Filing on Google Icon
8/14/2024Raffles Associates LP4,357,781$4.35M4.9%+35.8%2.308%Search for SEC Filing on Google Icon
8/14/2024Logos Global Management LP4,700,000$4.69M0.4%-24.8%2.489%Search for SEC Filing on Google Icon
8/12/2024XTX Topco Ltd61,515$61K0.0%N/A0.033%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC583,622$0.58M0.0%+10.0%0.309%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers132,491$0.13M0.0%+15.1%0.070%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp435,958$0.44M0.0%+35.7%0.231%Search for SEC Filing on Google Icon
5/17/2024Comerica Bank250,295$0.37M0.0%+84,745.8%0.133%Search for SEC Filing on Google Icon
5/15/2024Price T Rowe Associates Inc. MD161,314$0.24M0.0%+77.5%0.085%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.8,373,771$12.39M0.0%-0.1%4.435%Search for SEC Filing on Google Icon
4/16/2024Fifth Third Wealth Advisors LLC20,000$30K0.0%N/A0.011%Search for SEC Filing on Google Icon
2/13/2024DCF Advisers LLC94,751$0.10M0.1%+14.5%0.054%Search for SEC Filing on Google Icon
1/23/2024Defender Capital LLC.4,969,675$5.42M1.9%-4.1%2.840%Search for SEC Filing on Google Icon
1/12/2024SG Americas Securities LLC30,889$34K0.0%+61.6%0.018%Search for SEC Filing on Google Icon
12/6/2023Citigroup Inc.133,051$0.16M0.0%-16.2%0.076%Search for SEC Filing on Google Icon
11/15/2023Laurion Capital Management LP1,136,471$1.34M0.0%-42.2%0.649%Search for SEC Filing on Google Icon
11/13/2023Connor Clark & Lunn Investment Management Ltd.182,561$0.22M0.0%-27.9%0.104%Search for SEC Filing on Google Icon
11/13/2023Rathbones Group PLC35,000$41K0.0%N/A0.020%Search for SEC Filing on Google Icon
10/23/2023Defender Capital LLC.5,184,510$6.12M2.2%+1.5%2.963%Search for SEC Filing on Google Icon
9/21/2023Barclays PLC25,905$36K0.0%+87.3%0.015%Search for SEC Filing on Google Icon
8/15/2023Raffles Associates LP1,597,739$2.25M3.0%+4.0%0.913%Search for SEC Filing on Google Icon
8/4/2023American International Group Inc.62,114$88K0.0%N/A0.036%Search for SEC Filing on Google Icon
8/2/2023MAI Capital Management951,578$1.34M0.0%+123.8%0.545%Search for SEC Filing on Google Icon
8/1/2023Fort Sheridan Advisors LLC83,931$0.12M0.0%+13.5%0.049%Search for SEC Filing on Google Icon
7/18/2023Defender Capital LLC.5,109,710$7.20M2.5%-0.5%3.003%Search for SEC Filing on Google Icon
7/10/2023Trust Co. of Toledo NA OH35,394$50K0.0%+41.6%0.021%Search for SEC Filing on Google Icon
6/1/2023Prelude Capital Management LLC16,688$25K0.0%N/A0.010%Search for SEC Filing on Google Icon
5/15/2023Fort Sheridan Advisors LLC73,931$0.11M0.0%-11.9%0.043%Search for SEC Filing on Google Icon
5/12/2023Long Focus Capital Management LLC175,000$0.26M0.0%-18.6%0.103%Search for SEC Filing on Google Icon
5/11/2023PFG Investments LLC20,200$30K0.0%N/A0.012%Search for SEC Filing on Google Icon
5/10/2023Summit X LLC21,925$33K0.0%-26.7%0.013%Search for SEC Filing on Google Icon
5/10/2023MAI Capital Management425,115$0.64M0.0%-6.9%0.250%Search for SEC Filing on Google Icon
5/10/2023Connor Clark & Lunn Investment Management Ltd.241,022$0.36M0.0%-8.0%0.142%Search for SEC Filing on Google Icon
5/9/2023Y Intercept Hong Kong Ltd66,298$99K0.0%N/A0.039%Search for SEC Filing on Google Icon
5/5/2023Truist Financial Corp42,591$64K0.0%N/A0.025%Search for SEC Filing on Google Icon
5/1/2023Virtu Financial LLC17,521$26K0.0%-60.6%0.010%Search for SEC Filing on Google Icon
4/27/2023Defender Capital LLC.5,136,085$7.70M2.7%+0.8%3.019%Search for SEC Filing on Google Icon
4/27/2023Simplicity Solutions LLC48,000$72K0.0%N/A0.028%Search for SEC Filing on Google Icon
4/20/2023Strategic Wealth Investment Group LLC18,553$47K0.0%-41.2%0.011%Search for SEC Filing on Google Icon
4/18/2023ETF Managers Group LLC318,596$0.48M0.0%-10.0%0.187%Search for SEC Filing on Google Icon
4/4/2023Trust Co. of Toledo NA OH25,000$38K0.0%N/A0.015%Search for SEC Filing on Google Icon
3/23/2023ETF Managers Group LLC353,991$0.41M0.0%+7.3%0.208%Search for SEC Filing on Google Icon
2/14/2023683 Capital Management LLC128,840$0.15M0.0%N/A0.076%Search for SEC Filing on Google Icon
2/10/2023Connor Clark & Lunn Investment Management Ltd.261,902$0.31M0.0%-9.2%0.154%Search for SEC Filing on Google Icon
2/9/2023MAI Capital Management456,817$0.53M0.0%-12.5%0.269%Search for SEC Filing on Google Icon
2/9/2023Citigroup Inc.477,174$0.56M0.0%+250.9%0.281%Search for SEC Filing on Google Icon
2/8/2023Lincoln National Corp155,700$0.18M0.0%-28.5%0.092%Search for SEC Filing on Google Icon
1/12/2023Defender Capital LLC.5,093,535$5.96M2.4%-1.7%2.997%Search for SEC Filing on Google Icon
11/15/2022Laurion Capital Management LP2,377,940$2.69M0.0%-1.8%1.399%Search for SEC Filing on Google Icon
11/15/2022ETF Managers Group LLC329,826$0.37M0.0%+8.2%0.194%Search for SEC Filing on Google Icon
11/14/2022Raffles Associates LP2,080,536$2.35M2.5%+7.8%1.226%Search for SEC Filing on Google Icon
11/14/2022Lazard Asset Management LLC77,974$88K0.0%N/A0.046%Search for SEC Filing on Google Icon
11/14/2022Ergoteles LLC490,895$0.56M0.0%-11.3%0.289%Search for SEC Filing on Google Icon
11/10/2022Connor Clark & Lunn Investment Management Ltd.288,299$0.33M0.0%+113.0%0.170%Search for SEC Filing on Google Icon
11/10/2022Phoenix Holdings Ltd.47,587$55K0.0%-73.2%0.028%Search for SEC Filing on Google Icon
11/4/2022Lincoln National Corp217,700$0.25M0.0%-13.4%0.128%Search for SEC Filing on Google Icon
10/21/2022Strategic Wealth Investment Group LLC37,008$42K0.0%-25.6%0.022%Search for SEC Filing on Google Icon
10/18/2022Defender Capital LLC.5,184,035$5.86M2.3%+1.0%3.054%Search for SEC Filing on Google Icon
8/15/2022Laurion Capital Management LP2,422,367$3.83M0.1%N/A1.427%Search for SEC Filing on Google Icon
8/10/2022Dowling & Yahnke LLC32,263$51K0.0%N/A0.019%Search for SEC Filing on Google Icon
8/8/2022Y Intercept Hong Kong Ltd44,829$71K0.0%N/A0.026%Search for SEC Filing on Google Icon
8/8/2022Strategic Wealth Investment Group LLC49,736$79K0.0%-20.4%0.029%Search for SEC Filing on Google Icon
8/5/2022Connor Clark & Lunn Investment Management Ltd.135,328$0.21M0.0%+1,027.7%0.080%Search for SEC Filing on Google Icon
8/2/2022Lincoln National Corp251,500$0.40M0.0%+30.4%0.148%Search for SEC Filing on Google Icon
7/26/2022Defender Capital LLC.5,131,935$8.11M3.2%+2.5%3.024%Search for SEC Filing on Google Icon
7/19/2022MAI Capital Management247,735$0.39M0.0%N/A0.146%Search for SEC Filing on Google Icon
6/7/2022Defender Capital LLC.5,006,185$7.98M2.8%+0.2%2.949%Search for SEC Filing on Google Icon
5/11/2022GSA Capital Partners LLP72,506$0.11M0.0%N/A0.043%Search for SEC Filing on Google Icon
5/10/2022Phoenix Holdings Ltd.111,545$0.17M0.0%-9.9%0.066%Search for SEC Filing on Google Icon
5/9/2022Fort Sheridan Advisors LLC75,931$0.12M0.0%+43.5%0.045%Search for SEC Filing on Google Icon
4/28/2022DekaBank Deutsche Girozentrale402,100$0.61M0.0%+10.0%0.237%Search for SEC Filing on Google Icon
2/15/2022Raffles Associates LP543,590$1.33M1.3%+480.8%0.322%Search for SEC Filing on Google Icon
2/14/2022Long Focus Capital Management LLC215,000$0.53M0.1%N/A0.128%Search for SEC Filing on Google Icon
2/14/2022DAFNA Capital Management LLC80,000$0.20M0.0%N/A0.047%Search for SEC Filing on Google Icon
2/14/2022ETF Managers Group LLC207,735$0.52M0.0%N/A0.123%Search for SEC Filing on Google Icon
2/14/2022Williams Jones Wealth Management LLC.101,300$0.25M0.0%N/A0.060%Search for SEC Filing on Google Icon
2/10/2022Bailard Inc.63,400$0.16M0.0%N/A0.038%Search for SEC Filing on Google Icon
2/9/2022Principal Financial Group Inc.78,742$0.19M0.0%-36.6%0.047%Search for SEC Filing on Google Icon
2/9/2022Lazard Asset Management LLC21,610$52K0.0%N/A0.013%Search for SEC Filing on Google Icon
2/8/2022ProShare Advisors LLC27,397$67K0.0%+70.5%0.016%Search for SEC Filing on Google Icon
2/8/2022Northern Trust Corp1,080,924$2.65M0.0%-27.8%0.641%Search for SEC Filing on Google Icon
2/7/2022SG Americas Securities LLC31,542$77K0.0%-58.4%0.019%Search for SEC Filing on Google Icon
2/7/2022Phoenix Holdings Ltd.123,866$0.31M0.0%N/A0.073%Search for SEC Filing on Google Icon
2/2/2022DekaBank Deutsche Girozentrale365,500$0.89M0.0%-33.5%0.217%Search for SEC Filing on Google Icon
2/1/2022Defender Capital LLC.4,997,870$12.25M3.9%+4.2%2.965%Search for SEC Filing on Google Icon
1/28/2022Allspring Global Investments Holdings LLC522,913$1.28M0.0%N/A0.310%Search for SEC Filing on Google Icon
1/26/2022Straight Path Wealth Management16,200$40K0.0%N/A0.010%Search for SEC Filing on Google Icon
1/26/2022Lincoln National Corp193,500$0.47M0.0%+25.2%0.115%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Lineage Cell Therapeutics logo
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for unmet medical needs in the United States and internationally. The company develops OpRegen, an allogeneic retinal pigment epithelium cell replacement therapy, which is in Phase 2a clinical trial for the treatment of the dry age-related macular degeneration; OPC1, an allogeneic oligodendrocyte progenitor cell therapy that is in Phase 1/2a multicenter clinical trial for the treatment of cervical spinal cord injuries; and VAC, an allogeneic cancer immunotherapy of antigen-presenting dendritic cells, which is in Phase I clinical trial to treat non-small cell lung cancer. It also offers ANP1, an allogeneic auditory neuron progenitor cell transplant, which is in preclinical development for the treatment of debilitating hearing loss; and PNC1, an allogeneic photoreceptor cell transplant, which is in preclinical development for the treatment of vision loss due to photoreceptor dysfunction or damage. In addition, the company engages in the research and development of therapeutic products for retinal diseases, neurological diseases, and disorders and oncology. Lineage Cell Therapeutics, Inc. has a collaboration with Immunomic Therapeutics, Inc., for the treatment of glioblastoma multiforme. The company was formerly known as BioTime, Inc. and changed its name to Lineage Cell Therapeutics, Inc. in August 2019. Lineage Cell Therapeutics, Inc. was incorporated in 1990 and is headquartered in Carlsbad, California.
Read More on Lineage Cell Therapeutics

Today's Range

Now: $0.50
Low: $0.50
High: $0.62

50 Day Range

MA: N/A

52 Week Range

Now: $0.50
Low: $0.50
High: $1.61

Volume

15,528,898 shs

Average Volume

890,859 shs

Market Capitalization

$95.16 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.28

Who are the company insiders with the largest holdings of Lineage Cell Therapeutics?

Lineage Cell Therapeutics' top insider investors include:
  1. Broadwood Partners, LP (Director)
  2. Brian M Culley (CEO)
  3. Don M Bailey (Director)
  4. Jill Ann Howe (CFO)
Learn More about top insider investors at Lineage Cell Therapeutics.

Who are the major institutional investors of Lineage Cell Therapeutics?

Lineage Cell Therapeutics' top institutional shareholders include:
  1. Defender Capital LLC. — 2.65%
  2. Raffles Associates LP — 2.39%
  3. Geode Capital Management LLC — 1.95%
  4. State Street Corp — 1.38%
  5. MAI Capital Management — 0.89%
  6. Barclays PLC — 0.11%
Learn More about top institutional investors of Lineage Cell Therapeutics stock.

Which major investors are selling Lineage Cell Therapeutics stock?

Within the previous quarter, LCTX stock was sold by these institutional investors:
  1. Jane Street Group LLC
  2. HighTower Advisors LLC
  3. Connor Clark & Lunn Investment Management Ltd.

Which major investors are buying Lineage Cell Therapeutics stock?

During the previous quarter, LCTX stock was acquired by institutional investors including:
  1. Barclays PLC
  2. Barclays PLC
  3. Raffles Associates LP
  4. GSA Capital Partners LLP
  5. Geode Capital Management LLC
  6. SG Americas Securities LLC
  7. State Street Corp
  8. MAI Capital Management
Within the previous year, these company insiders have bought Lineage Cell Therapeutics stock:
  1. Broadwood Partners, LP (Director)
  2. Brian M Culley (CEO)
  3. Don M Bailey (Director)
  4. Jill Ann Howe (CFO)
Learn More investors buying Lineage Cell Therapeutics stock.
JD Vance Predicts: Wall Street vs. Trump & Your Money
From Priority Gold   |   Ad
Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.
Get your free guide NOW before it's too late.